Drugs / Neoantigen-based DC immune preparation
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05749627 | Apr 2023 → Dec 2025 overdue | cancer | The First Affiliated Hospital of Nanchang University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Neoantigen-based DC immune preparation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05749627 ↗ |
| Modality | Cell therapy | “neoantigen-based DC treatment” NCT05749627 ↗ |